HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason D Theis Selected Research

Congo Red

3/2022Somatostatin-derived amyloidosis: a novel type of amyloidosis associated with well-differentiated somatostatin-producing neuroendocrine tumours.
1/2022The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
12/2021Association between spinal stenosis and wild-type ATTR amyloidosis.
1/2021Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
9/2018Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation.
1/2018Pathology and diagnosis of renal non-AL amyloidosis.
2/2017Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype.
1/2017Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
1/2016Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.
7/2014Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason D Theis Research Topics

Disease

41Amyloidosis
09/2022 - 12/2009
19Amyloid Plaque
09/2022 - 10/2011
7Glomerulonephritis
01/2021 - 08/2012
7Familial Amyloidosis (Hereditary Amyloidosis)
11/2018 - 07/2011
6Immunoglobulin Light-chain Amyloidosis
01/2019 - 02/2011
6Paraproteinemias (Monoclonal Gammopathy)
01/2019 - 11/2010
4Proteinuria
01/2021 - 09/2013
3Hematuria
01/2021 - 03/2013
3Transthyretin-Related Hereditary Amyloidosis
01/2019 - 02/2011
3Nephrotic Syndrome (Syndrome, Nephrotic)
01/2017 - 07/2011
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2017 - 05/2009
2Heart Failure
11/2018 - 12/2011
2Chronic Renal Insufficiency
01/2017 - 01/2016
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
11/2014 - 07/2009
2Chronic Kidney Failure (Chronic Renal Failure)
08/2014 - 10/2011
2Multiple Myeloma
04/2014 - 11/2010
1Sclerosis
01/2021
1Peripheral Nervous System Diseases (PNS Diseases)
11/2018
1Sjogren's Syndrome (Sjogren Syndrome)
02/2017
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2017
1Plasma Cell Neoplasms
04/2015
1Autoimmune Diseases (Autoimmune Disease)
02/2014
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2013
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2013
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
03/2013
1Lymphoma (Lymphomas)
01/2013
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2013
1Hyperplasia
01/2013
1Acquired Immunodeficiency Syndrome (AIDS)
07/2012
1Cardiomyopathies (Cardiomyopathy)
12/2011
1Hepatitis B
07/2011
1Chronic Hepatitis B
07/2011
1Acute Kidney Injury (Acute Renal Failure)
11/2010
1Retinoblastoma (Glioblastoma, Retinal)
05/2009

Drug/Important Bio-Agent (IBA)

28Amyloid (Amyloid Fibrils)IBA
09/2022 - 11/2010
27Proteins (Proteins, Gene)FDA Link
03/2022 - 05/2009
13Congo RedIBA
03/2022 - 07/2011
12Immunoglobulins (Immunoglobulin)IBA
01/2021 - 05/2009
10Peptides (Polypeptides)IBA
05/2021 - 03/2013
7GelsolinIBA
11/2018 - 02/2011
5Chemotactic FactorsIBA
05/2021 - 09/2013
5Prealbumin (Transthyretin)IBA
11/2018 - 02/2011
5Fibrinogen (Factor I)FDA Link
01/2018 - 01/2012
5AA amyloidosisIBA
01/2018 - 07/2011
5Complement System Proteins (Complement)IBA
01/2017 - 05/2009
5Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
04/2015 - 11/2012
5Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2014 - 07/2011
5Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2014 - 10/2011
4CreatinineIBA
01/2021 - 09/2013
4Amyloidogenic ProteinsIBA
01/2018 - 05/2013
4ApolipoproteinsIBA
01/2018 - 01/2013
3ParaffinIBA
01/2021 - 05/2014
3Immunoglobulin G (IgG)IBA
01/2020 - 11/2010
3Serum Amyloid P-ComponentIBA
01/2018 - 01/2013
3Muramidase (Lysozyme)IBA
02/2017 - 01/2012
3apolipoprotein A-IV (apolipoprotein AIV)IBA
01/2016 - 01/2012
3ProteomeIBA
07/2014 - 05/2014
2Mutant Proteins (Protein, Mutant)IBA
11/2018 - 09/2018
2Apolipoprotein C-II (ApoC2)IBA
09/2018 - 02/2017
2Dichlorodiphenyldichloroethane (DDD)IBA
01/2017 - 05/2009
2Formaldehyde (Formol)FDA Link
04/2015 - 05/2014
2Insulin (Novolin)FDA Link
06/2014 - 11/2012
2Antigen-Antibody Complex (Immune Complex)IBA
05/2013 - 05/2009
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2022
1Extracellular Matrix ProteinsIBA
02/2021
1fibulinIBA
02/2021
1Epidermal Growth Factor (EGF)IBA
02/2021
1Immune Sera (Antisera)IBA
01/2021
1Coloring Agents (Dyes)IBA
01/2021
1patisiranIBA
01/2019
1InotersenIBA
01/2019
1tafamidisIBA
01/2019
1Periodic AcidIBA
09/2018
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2017
1Apolipoproteins E (ApoE)IBA
01/2017
1Enfuvirtide (Fuzeon)FDA Link
06/2014
1Pharmaceutical PreparationsIBA
06/2014
1Apolipoprotein A-II (Apolipoprotein A2)IBA
09/2013
1Phosphotransferases (Kinase)IBA
01/2013
1Histone Deacetylases (Histone Deacetylase)IBA
12/2011
1DNA (Deoxyribonucleic Acid)IBA
02/2011
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
12/2010
1myosin-binding protein CIBA
07/2009
1Ventricular MyosinsIBA
07/2009
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2009
1Cyclin D2IBA
05/2009
1CyclinsIBA
05/2009

Therapy/Procedure

18Lasers (Laser)
05/2021 - 12/2009
3Therapeutics
01/2019 - 03/2014
3Drug Therapy (Chemotherapy)
08/2014 - 10/2011
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021
1Injections
06/2014